Clin Cancer Res
http://www.ncbi.nlm.nih.gov/pubmed/37773632
29(24):5128-5139
https://connects.catalyst.harvard.edu/Profiles/profile/220726611
Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma.
Clin Cancer Res
http://www.ncbi.nlm.nih.gov/pubmed/37773632
29(24):5128-5139
https://connects.catalyst.harvard.edu/Profiles/profile/220726611